Pubblicazioni

• Pubblicazioni
  • Pitfalls of antinuclear antibody detection in systemic lupus erythematosus: the positive experience of a national multicentre study
  • Anti-cyclic citrullinated peptide antibody titer predicts time to rheumatoid arthritis onset in patients with undifferentiated arthritis: results from a 2-year prospective study
  • Anti-Ro/SSA-p200 antibodies in the prediction of congenital heart block. An Italian multicentre cross-sectional study on behalf of the “Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA) Group”
  • Detection of anti-IFI16 antibodies by ELISA: clinical and serological associations in systemic sclerosis
  • Diagnostic accuracy of currently available anti-double-stranded DNA antibody assays. An Italian multicentre study
  • Diagnostic value of anti-mutated citrullinated vimentin in comparison to anti-cyclic citrullinated peptide and anti-viral citrullinated peptide 2 antibodies in rheumatoid arthritis: An Italian multicentric study and review of the literature
  • Evaluation of Current Methods for the Measurement of Serum Anti–Double-Stranded DNA Antibodies
  • From ANA-screening to antigen-specificity: an EASI-survey on the daily practice in European countries
  • International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies
  • Nuclear DNA sensor IFI16 as circulating protein in autoimmune diseases is a signal of damage that impairs endothelial cells through high-affinity membrane binding.
  • Second generation analysis of antinuclear antibody (ANA) by combination of screening and confirmatory testing
  • Validation of a new immunoenzymatic method to detect antibodies to RNA polymerase III in systemic sclerosis
  • An international survey on anti-neutrophil cytoplasmic antibodies (ANCA) testing in daily clinical practice

LINEE GUIDA IN EVIDENZA

tutti le linee guida

PROGETTI IN EVIDENZA

tutti i progetti